$10.67
0.707.02%
At close: -
$10.67
0.000.00%
After Hours: Jan 3, 4:01 PM EDT
Artiva Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Artiva Biotherapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-0.92 | $-0.91 | -1.10 % |
Q2 | 2024-08-29 | $-22.00 | $-4.40 | -400.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $0 | $70.00K | -100.0 % |
Q2 | 2024-08-29 | $0 | $70.00K | -100.0 % |
Artiva Biotherapeutics (ARTV) is scheduled to report earnings on February 22, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.92, which missed the estimate of $-0.91.
The Actual Revenue was $0K, which missed the estimate of $70K.
Browse earnings estimates, EPS, and revenue on all stocks.